DARUNAVIR
Darunavir is an HIV protease inhibitor that prevents cleavage of viral polyproteins, producing immature, noninfectious virions. Benefits include high potency and activity against resistant strains. Side effects include rash, hepatotoxicity, hyperlipidemia, nausea, and increased cardiovascular risk, especially when combined with boosting agents. Only GMP materials will be supplied, logistics all according to GDP.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
DARUNAVIR demonstrates a highgranularity biochemical interaction profile spanning catalyticdomain modulation, multilayer signalling interference, mitochondrialnetwork recalibration, redoxstate restructuring, ionflux redistribution, membraneelectrochemical modulation, cytoskeletalarchitecture remodelling and transcriptionfactor axis reprogramming. Its molecular topology supports interactions with catalytic residues, allosteric regulatory surfaces, transmembrane helices, hydrophobic receptor pockets, nucleotidebinding cavities, redox-buffer modules and polymeric scaffolding proteinsenabling broad influence across metabolic, genomic, electrophysiological and structural regulatory networks.
Mechanistically, DARUNAVIR may reshape phosphorylationflow geometry across ERK/MAPK/JNK/p38 cascades, modulate PI3KAKT survivalpathway architecture, alter Gprotein coupling logic, redistribute Ca²⁺ microdomains, shift IP/DAG signal amplitude, and recalibrate cAMPPKA oscillatory behaviour. Mitochondrial effects include ETCcomplex rebalancing, ATP/ADP flux modulation, ROSthreshold displacement, mitochondrialmembrane potential polarity shifts and ERmitochondria bidirectional stresssignal integration.
Advanced
- Kinomescale catalyticcascade interference and pathway reconstruction
- Ultraresolution receptor/ligand docking and conformationaltransition modelling
- UPR/ERstress, mitophagy, autophagy and oxidativestress crosstalk research
- Deep multiomics network reconstruction (RNAseq, metabolomics, proteomics, phosphoproteomics)
- Cytoskeletal tensionmapping, polymer turnover and mechanosignalling analytics
- Apoptosis, necroptosis, ferroptosis, pyroptosis and parthanatos modelling
- Machinelearning SAR/QSAR pipelines for predictive molecular optimisation
Toxicodynamics & Hazard Spectrum
- Rapid ROS accumulation and antioxidantbuffer system collapse
- Mitochondrial fragmentation, membranepotential failure or ETC inhibition
- Severe Na⁺/K⁺/Ca²⁺ ionhomeostasis disruption
- Cytoskeletal depolymerisation, actin/tubulin instability and loss of cellular mechanics
- membrane-integrity failure and lipidbilayer thinning
- NF-κB, STAT and IRF inflammatoryaxis hyperactivation
- Engagement of multiaxis programmed-cell-death pathways
- Epigenetic drift across methylation/acetylation domains
For expert laboratory research only not intended for biological or therapeutic exposure.
Only GMP materials will be supplied, logistics all according to GDP.
Datasheet
| Molecular Formula | C27H37N3O7S |
|---|---|
| Molecular Weight | 547.7 g/mol |
| CAS Number | 206361-99-1 |
| Storage Condition | Store Prezista tablets at 25 °C (77 °F); with excursions permitted to 15 deg – 30 °C (59 deg – 86 °F). |
| Solubility | Approximately 0.15 mg/mL at |
| Purity | Purity information is available upon request (COA). |
| Synonym | Darunavir; 206361-99-1; TMC114; TMC-114; UIC-94017 |
| IUPAC/Chemical Name | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate |
| InChl Key | CJBJHOAVZSMMDJ-HEXNFIEUSA-N |
| InChl Code | InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
